Last Update:
May 31, 2017
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
Journal
Papers, Abstracts, and Commentaries
| |
|
Bone mineral density reductions after tenofovir disoproxil
fumarate initiation and changes in phosphaturia: a secondary analysis of
ACTG A5224s.
Gupta SK, Yeh E, Kitch DW, Brown
TT,et al
J Antimicrob Chemother. 2017 Mar 2
Abstract
Bone Mineral Density and Vitamin D Levels in HIV Treatment-Naïve African
American Individuals Randomized to Receive HIV Drug Regimens.
Cook PP, Stang AT, Walker LR, A
South Med J. 2016
Nov;109(11):712-717.
Abstract
No Decrease in Knee Survivorship or Outcomes Scores for Patients With HIV Infection
Who Undergo TKA.
Issa K, Pierce TP, Harwin SF,
et al
Clin Orthop Relat Res. 2016
Oct 14.
Abstract
HIV and Bone Complications: Understudied Populations and New Management
Strategies.
Yin MT, Brown TT.
Curr HIV/AIDS Rep. 2016 Oct 11. R
Abstract
Factors associated with fractures in HIV-infected persons: which
factors matter?
Gedmintas L, Wright EA, Dong Y
Osteoporos Int.
2016 Jul 15.
Abstract
HIV infection and bone disease.
Compston J.
J Intern Med.
2016 Jun 6.
Abstract
Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of
bone health in HIV-1-infected subjects: comparison with dual X-ray
absorptiometry.
Fantauzzi A, Floridia M, Ceci F,
HIV AIDS (Auckl).
2016 May 31;8:109-17
Abstract
Bone health and HIV in resource-limited settings: a scoping review.
Matovu FK, Wattanachanya L, Beksinsk M,
et al
Curr Opin HIV AIDS. 2016
Mar 25
Abstract
Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV
Infection: Clinical Features, Treatment, and Outcome.
Williamson BT, Leitch HA.
Case Rep Hematol.
2016;2016:8502641.
Abstract
Mechanisms of bone disease in HIV and hepatitis C virus: impact
of bone turnover, tenofovir exposure, sex steroids and severity of liver
disease.
Bedimo R, Cutrell J, Zhang S,
et al
AIDS.
2015 Nov 10
Abstract
Bone loss in HIV: a contemporary review.
Hileman CO, Eckard AR, McComsey GA.
Curr Opin Endocrinol Diabetes Obes.
2015 Sep 24.
Abstract
FULL-TEXT JOURNAL
Bone disease
in HIV - Research Initiative Treatment Action
(RITA),
focused on HIV-related bone density and fracture.
An interview with Michael Yin offers insights on bone disease risk factors,
screening, and care.
Four review articles analyze (1) fracture prevalence and incidence with HIV,
(2) bone density risk factors in HIV populations, (3) when to use and how to
interpret FRAX and DXA, and (4) treatment. The latter two articles focus
largely on the 2015 HIV bone guidelines in
Clinical Infectious
Diseases.
Journal
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral
Therapy Initiation: A Randomized Trial.
Overton ET, Chan ES, Brown TT, et al
Ann Intern Med.
2015 Jun 16;
Abstract
Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.
Erlandson KM, O'Riordan M, Hileman CO,
et al
AIDS Res Hum Retroviruses.
2015 Apr 28.
Abstract
FULL-TEXT ARTICLE
Prevalence and risk
factors for patient-reported joint pain among patients with HIV/Hepatitis C
coinfection, Hepatitis C monoinfection, and monoinfection.
Ogdie A, Pang WG, Forde KA, et al
BMC Musculoskelet Disord. 2015
Apr 19;16(1):93.
Paper
Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and
HIV-Monoinfected Women.
Lo Re V
3rd, Lynn K, Stumm ER, et al
J Infect Dis.
2015 Mar 9.
Abstract
Bone Alterations Associated with HIV.
Warriner AH, Mugavero M, Overton ET
Curr HIV/AIDS Rep. 2014 Jul 27.
Abstract
Skeletal health in adults with HIV infection.
Bolland MJ, Grey A, Reid IR.
Lancet Diabetes Endocrinol.
2014 Feb 26.
Abstract
Consensus statement: Recommendations for the management of
metabolic bone disease in human immunodeficiency virus patients.
Martínez E, Jódar Gimeno E, Reyes García R,
Enferm Infecc Microbiol Clin. 2013 Dec
10.
Abstract
The effects of untreated and treated HIV infection on
bone disease.
Cotter AG, Mallon PW.
Curr Opin HIV AIDS.
2013 Nov 20
Abstract
Peak Bone Mass in Young HIV-Infected Patients Compared
With Healthy Controls.
Negredo E, Domingo P, Ferrer E, et al
J Acquir Immune Defic Syndr. 2013 Oct
Abstract
Bone and vitamin D metabolism in HIV.
Panayiotopoulos A, Bhat N, Bhangoo A.
Rev Endocr Metab Disord.
2013 May 9.
Abstract |
Bone turnover markers in HIV-infected patients before starting antiretroviral
therapy.
Martín-Morales R, Ruiz J,
et
al
J Int AIDS Soc. 2012 Nov
11;15(6):18321.
Abstract
Avascular necrosis of femoral head in patients with human immunodeficiency
virus type 1 (HIV-1) infection: a single-centre experience.
Wilmes D, Docquier P, Belkhir L, et al
J Int AIDS Soc. 2012
Nov 11;15(6):18325.
Abstract
Fractures after antiretroviral initiation: An analysis of the
ACTG longitudinal linked randomized trial (ALLRT) study.
Yin MT, Kendall MA, Wu X, et
al
AIDS. 2012 Aug 28..
Abstract |
FULL-TEXT
ARTICLE
Is There an Increased Risk of Post-Operative Surgical Site Infection after
Orthopaedic Surgery in HIV Patients?
A Systematic Review and Meta-Analysis.
Kigera JW, Straetemans M, Vuhaka SK, et
al
PLoS One.
2012;7(8):e42254..
Papers
The changing spectrum of rheumatic disease in HIV infection.
Lawson E, Walker-Bone K.
Br Med Bull. 2012 Aug 8
Abstract
Bone Loss in the HIV-Infected Patient:
Evidence, Clinical Implications, and Treatment Strategies.
Walker Harris V, Brown TT.
J Infect Dis.
2012 Jun;205 Suppl 3:S391-8.
Abstract |
HIV: Inflammation and Bone.
Ofotokun I, McIntosh E, Weitzmann MN.
Curr HIV/AIDS Rep.
2011 Dec 17.
Abstract |
HIV infection and bone disease: implications
for an aging population.
Cotter AG, Mallon PW.
Sex Health. 2011 Nov;8(4):493-501.
Abstract
HIV and bone metabolism.
Ofotokun I, Weitzmann MN.
Discov Med.
2011 May;11(60):385-93
Abstract
The Role of HIV and Antiretroviral Therapy in
Bone Disease.
Gutiérrez F, Masiá M.
AIDS Rev.
2011 Apr-Jun;13(2):109-18.
Abstract
Low CD4 Count is Associated with an Increased
Risk of Fragility Fracture in HIV-infected Patients.
Yong MK, Elliott JH, Woolley IJ, Hoy JF.
J Acquir Immune Defic Syndr.
2011 Apr 23
Abstract
Markers of bone turnover are elevated in patients
with antiretroviral treatment independent of the substance used.
Piso RJ, Rothen M, Rothen JP, Stahl M.
J Acquir Immune Defic Syndr.
2011 Apr;56(4):320-4.
Abstract
Alveolar Granulocytic Sarcoma of the Mandible in a
Patient with HIV.
Colović N, Jurišić V, Terzić T,
et al
Onkologie.
2011;34(1-2):55-8.|
Abstract
Prospective one-year bone loss in treatment-naïve HIV+ men and
women on single or multiple
drug HIV therapies.
Briot K, Kolta S, Flandre P,
et
al
Bone.
2011 Jan 26
Abstract
Bone Disease in HIV Infection: A Practical Review and
Recommendations for HIV Care
Providers.
McComsey GA, Tebas P, Shane E, et al
Clin Infect Dis.
2010 Sep 14
Abstract |
HIV and Bone Loss.
Arora S, Agrawal M, Sun L, et al
Curr Osteoporos Rep.
2010 Sep 10.
Abstract |
|
|
HIV and Bone Disease.
Stone B, Dockrell D, Bowman C, McCloskey E.
Arch Biochem Biophys.
2010 Jul 31
Abstract |
Bone Changes and Fracture Risk in Individuals
Infected With HIV.
Warriner AH, Mugavero MJ .
Curr Rheumatol Rep.
2010 Apr 28.
Abstract
|
HIV-Induced Abnormalities in Myelopoiesis and their
Recovery
Following Antiretroviral Therapy.
Andrea C, Simona G, Luca B, et al
Curr HIV Res.
2010 Mar 19.
Abstract |
FULL-TEXT ARTICLE
Operations about Hip in Human Immunodeficiency
Virus-Positive Patients..
Yoo JJ, Chun SH, Kwon YS,
et al
Clin Orthop Surg.
2010 Mar;2(1):22-7.
Paper |
|
|
|
|
|
|
Journal Papers, Abstracts, and
Commentaries
| |
Left ventricle thrombus after tranexamic acid for
spine surgery in an HIV positive patient.
Gerstein NS, Brierley JK, Culling MD.
Spine J. 2015 Oct 30.
Abstract
Prevalence, Comorbidities, and Risk of Perioperative
Complications in Human Immunodeficiency Virus-Positive Patients
Undergoing Cervical Spine Surgery.
Lovy AJ, Guzman JZ, Skovrlj B, et al
Spine (Phila Pa 1976).
2015 Nov;40(21):E1128-E1134..
Abstract
Diagnosis and treatment of spondylodiscitis in
HIV-positive patients.
Siewe J, Oppermann J, Eysel P, et al
Acta Orthop Belg.
2013 Oct;79(5):475-82.
Abstract
Primary spinal hydatid cyst in a patient with
acquired immunodeficiency syndrome.
Erayman I, Kalkan E, Erdi F, .et
Eur Spine J.
2010 Oct 31.
Abstract |
|
|
|
Journal Papers, Abstracts, and
Commentaries
| |
A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced
Bone Loss in Treatment-naïve HIV-infected Patients: a Phase IIb Trial.
Ofotokun I, Titanji K, Lahiri CD,
et al
Clin Infect Dis. 2016 May
18.
Abstract
Protecting bone in long-term HIV positive
patients receiving antiretrovirals.
McGinty T, Mallon P.
Expert Rev Anti Infect Ther.
2016 May 18
Abstract
Long-term use of protease inhibitors is associated with bone
mineral density loss.
Kinai E, Nishijima T, Mizushima D, et al
AIDS Res Hum Retroviruses.
2014 Feb 4.
Abstract
Effects of vitamin D deficiency and
combination antiretroviral therapy on bone in HIV-positive
patients.
Childs K, Welz T, Samarawickrama A, Post FA.
AIDS. 2011 Nov
22
Abstract
HIV-1 infection and antiretroviral therapies:
risk factors for osteoporosis and bone fracture.
Ofotokun I, Weitzmann MN.
Curr Opin Endocrinol Diabetes Obes.
2010 Sep 14
Abstract |
|
|
|
Journal Papers, Abstracts, and
Commentaries
| |
|
Serum total estradiol, but not testosterone is associated with reduced bone
mineral density (BMD) in HIV-infected men: a cross-sectional,
observational study.
Santi D, Madeo B, Carli F,
et al
Osteoporos Int.
2015 Oct 28.
Abstract
Long-term changes in bone mineral density after switching to
a protease inhibitor monotherapy in HIV-infected subject.
Negredo E, Bonjoch A, Puig J, et al
New Microbiol. 2015 Apr 29;38(2)..
Abstract
Prevalence and Predictors of Low Bone Mineral Density and
Fragility Fractures Among HIV-Infected Patients at One Italian Center After
Universal DXA Screening: Sensitivity and Specificity of Current Guidelines
on Bone Mineral Density Management.
Mazzotta E, Ursini T, Agostinone A, et al
AIDS Patient Care STDS. 2015 Feb 18.
Abstract
Utility of bone marrow examination for workup of fever of
unknown origin in patients with HIV/AIDS.
Quesada AE, Tholpady A, Wanger A,
et al
J Clin Pathol. 2015 Jan 14. pii:
jclinpath-2014-202715..
Abstract
Bone mineral density changes after 2 years of ARV treatment,
compared to naive HIV-1-infected patients not on HAART.
Rey D, Treger M, Sibilia J, et al
Scand J Infect Dis. 2014 Nov 26:1-8.
Abstract
Low bone mineral density in patients with well-suppressed HIV infection
is largely explained by body weight, smoking and prior advanced HIV
disease.
Kooij KW, Wit FW, Bisschop PH, et al
J Infect Dis. 2014
Sep 1.
Abstract
Bone Mineral Density Effects of Randomized Regimen and
Nucleoside Reverse Transcriptase Inhibitor Selection from ACTG A5142.
Huang JS, Hughes MD, Riddler SA, et al
HIV Clin Trials. 2013 Jan
1;14(5):224-234.
Abstract
FULL-TEXT
ARTICLE
Asessing the Association between Leptin and Bone Mineral Density
in HIV-Infected Men.
Rao MN, Schambelan M, Tai VW, et al
AIDS Res Treat.
2012;2012:103072.
Paper
|
Association of Regional Body Composition with Bone
Mineral Density in HIV-infected and Uninfected Women:
Women's
Interagency HIV Study.
Sharma A, Tian F, Yin MT, Keller MJ, Cohen M, Tien PC.
J Acquir Immune Defic Syndr.
2012 Aug 14.
Abstract
Therapeutic Options for Low Bone Mineral Density in
HIV-Infected Subjects.
Cotter AG, Mallon PW.
Curr HIV/AIDS Rep.
2012 Apr 17.
Abstract
Stable Bone Density in HAART-Treated
Individuals with HIV: A Metaanalysis.
Bolland MJ, Wang TK, Grey A, et al
J Clin Endocrinol Metab.
2011 Jun 29.
Abstract
Comparison of Changes in Bone Density and Turnover with
Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results
from the
ASSERT Study.
Stellbrink HJ, Orkin C, Arribas JR, et al
Clin Infect Dis.
2010 Sep
Abstract
Bone mineral density changes in protease inhibitor-sparing
vs. nucleoside reverse
transcriptase inhibitor-sparing highly active antiretroviral
therapy: data from a
randomized trial.
Hansen A, Obel N, Nielsen H, et
al
HIV Med.
2010 Aug 15.
Abstract
|
|
|
|
|
|
|
|
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
| |
An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to
HIV- men in the Multicenter AIDS Cohort Study (MACS).
Gonciulea A, Wang R, Althoff KN,
ET AL
AIDS. 2017 Apr 3.
Abstract
Fracture management in HIV positive individuals: a
systematic review.
Wijesekera MP, Graham SM, Lalloo DG,
et al
Int Orthop. 2016 Sep
21.
Abstract
How to predict the risk of fracture in HIV?
Yin MT, Falutz J.
Curr Opin HIV AIDS.
2016 Feb 25.
Abstract
Prevalence and Predictors of Low Bone Mineral Density and
Fragility Fractures Among HIV-Infected Patients at One Italian Center After
Universal DXA Screening: Sensitivity and Specificity of Current Guidelines on
Bone Mineral Density Management.
Mazzotta E, Ursini T, Agostinone A, et al
AIDS Patient Care STDS. 2015 Feb 18.
Abstract
Late implant sepsis after fracture surgery in HIV positive
patients.
Graham SM, Bates J, Mkandawire N, Harrison WJ.
Injury.
2015 Jan 7. pii: S0020-1383(14)00662-7.
Abstract
Role of bone mineral density in predicting morphometric vertebral
fractures in patients with HIV infection.
Porcelli T, Gotti D, Cristiano A, et al
Osteoporos Int. 2014 Jul 24
Abstract
Bones, Fractures, Antiretroviral Therapy and HIV.
Battalora LA, Young B, Overton ET.
Curr Infect Dis Rep. 2014 Feb;16(2):393.
Abstract
Complications related to fracture treatment
in HIV patients: A case report.
Randelli F, Pulici L, Favilla S, et a
lInjury.
2014 Feb;45(2):379-82.
Abstract
"HIV infection and its association with an excess risk of
clinical fractures and : a nation-wide case-control study.
Prieto-Alhambra D, Güerri-Fernández R, De Vries F, et
al
J Acquir Immune Defic Syndr.
2014 Jan 21
Abstract
Does human immunodeficiency virus status
affect early wound healing in open surgically stabilised
tibial fractures?: A prospective study.
Howard NE, Phaff M, Aird J, et al
Bone
Joint J. 2013 Dec 1;95-B(12):1703-7.
Abstract
Physiologic Frailty and Fragility Fracture in
HIV Infected Male Veterans.
Womack JA, Goulet JL, Gibert C, et al
Clin Infect Dis. 2013 Feb 1
Abstract |
HIV infection is strongly associated with hip fracture risk,
independently of age, gender and co-morbidities: A
population-based cohort study"
Güerri-Fernandez R, Vestergaard P, Carbonell C,
et al
J Bone Miner Res.
2013 Jan 29
Abstract |
HIV-1 infection and antiretroviral therapies:
risk factors for osteoporosis and bone fracture.
Ofotokun I, Weitzmann MN.
Curr Opin Endocrinol Diabetes Obes.
2010 Sep 14
Abstract |
|
|
|
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
Journal Papers, Abstracts, and
Commentaries
|
HIV
Musculoskeletal Main Page
